VINORELBINE AN vinorelbine (as tartrate) 50 mg/5 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

vinorelbine an vinorelbine (as tartrate) 50 mg/5 ml concentrated injection vial

amneal pharma australia pty ltd - vinorelbine tartrate, quantity: 69.25 mg (equivalent: vinorelbine, qty 50 mg) - injection, concentrated - excipient ingredients: water for injections - treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

VINORELBINE AG vinorelbine (as tartrate) 50 mg/5 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

vinorelbine ag vinorelbine (as tartrate) 50 mg/5 ml concentrated injection vial

medtas pty ltd - vinorelbine tartrate, quantity: 69.25 mg (equivalent: vinorelbine, qty 50 mg) - injection, concentrated - excipient ingredients: water for injections - treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

VINORELBINE EBEWE 10 mg/1 mL (as tartrate) injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

vinorelbine ebewe 10 mg/1 ml (as tartrate) injection vial

sandoz pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection, concentrated - excipient ingredients: nitrogen; water for injections - treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Hospira Vinorelbine Tartrate for injection vial 10 mg/1 mL Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vinorelbine tartrate for injection vial 10 mg/1 ml

hospira australia pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection - excipient ingredients: water for injections - vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (nsclc), as a single agent or in combination. it is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. in addition vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

Hospira Vinorelbine Tartrate for Injection 50 mg/5 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vinorelbine tartrate for injection 50 mg/5 ml vial

hospira australia pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection - excipient ingredients: water for injections - vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (nsclc), as a single agent or in combination. vinorelbine tartrate is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. in addition, vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

VINORELBINE- vinorelbine injection, solution United States - English - NLM (National Library of Medicine)

vinorelbine- vinorelbine injection, solution

hospira, inc. - vinorelbine tartrate (unii: 253gqw851q) (vinorelbine - unii:q6c979r91y) - vinorelbine 10 mg in 1 ml - vinorelbine injection, usp is indicated: none pregnancy category d risk summary vinorelbine can cause fetal harm when administered to a pregnant woman. in animal reproduction studies in mice and rabbits, embryo and fetal toxicity were observed with administration of vinorelbine at doses approximately 0.33 and 0.18 times the human therapeutic dose, respectively. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, apprise the patient of the potential hazard to a fetus. animal data in a mouse embryofetal development study, administration of a single dose of vinorelbine at a dose level of 9 mg/m2 or greater (approximately 0.33 times the recommended human dose based on body surface area) was embryotoxic and fetotoxic. vinorelbine was embryotoxic and fetotoxic to pregnant rabbits when administered every 6 days during the period of organogenesis at doses of 5.5 mg/m2 (approximately 0.18 times the recommended human dose based on body surface area) or greater. at doses t

VINORELBINE TARTRATE INJECTION USP SOLUTION Canada - English - Health Canada

vinorelbine tartrate injection usp solution

sandoz canada incorporated - vinorelbine (vinorelbine tartrate) - solution - 10mg - vinorelbine (vinorelbine tartrate) 10mg - antineoplastic agents

Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vinorelbine tartrate 50 mg/5 ml injection vial

hospira australia pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml - injection - excipient ingredients: water for injections - vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (nsclc). in patients with stage iv nsclc, vinorelbine is indicated as a single agent or in combination with cisplatin. in stage iii nsclc, vinorelbine is indicated in combination with cisplatin.

Vinorelbine Strides 10mg per ml (1ml vial) Malta - English - Medicines Authority

vinorelbine strides 10mg per ml (1ml vial)

strides arcolab international limited unit 4, metro centre, tolpits lane, watford, hertfordshire, wd 189 ss, united kingdom - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

Vinorelbine Strides 10mg per ml (5ml vial) Malta - English - Medicines Authority

vinorelbine strides 10mg per ml (5ml vial)

strides arcolab international limited unit 4, metro centre, tolpits lane, watford, hertfordshire, wd 189 ss, united kingdom - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents